Chantix increases risk of heart attack or arrhythmia
Chantix associated with 72 percent increased risk of serious CV events — Popular smoking cessation drug significantly increases risk of hospitalization due to serious cardiovascular problems – Smoking cigarettes is a dangerous habit that many are struggling to break, but for the smokers who choose to use one of the most popular smoking cessation drugs on the market, new warnings about the risk of serious cardiovascular events are on their way. Use of varenicline ? marketed by Pfizer under the brand name Chantix ? is associated with a 72 percent increased risk of hospitalization due to a serious adverse cardiovascular (CV) event, such as heart attack or arrhythmia.